Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
Guan‐Jhou Chen(National Taiwan University Hospital), Chien‐Ching Hung(National Taiwan University), Yu‐Shan Huang(Capital Medical University), Hsin‐Yun Sun(National Taiwan University Hospital), Aristine Cheng(Far Eastern Memorial Hospital), Sung‐Hsi Huang(National Taiwan University), Yi‐Ching Su(National Taiwan University Hospital), Wen‐Chun Liu(National Taiwan University Hospital), Yi‐Chia Huang(National Taiwan University Hospital), Sui‐Yuan Chang(National Taiwan University of Science and Technology)
Cited by 24
Related Papers
Animal models for COVID-19
|Nature|2020|877
Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure
|Journal of Bacteriology|1987|512
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics
|Nature Biomedical Engineering|2021|433
Prolonged virus shedding even after seroconversion in a patient with COVID-19
|Journal of Infection|2020|302